Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of two digoxin dosing methods for symptoms and heart rate
IRCT20110512006463N2Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Mar 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of digoxin in arrhythmia, heart failure (HF) and Atrial fibrillation (AFib), sponsored by Islamic Azad University. Primary endpoint: Changes in heart rate. Started Mar 2011; status: completed.
02
Drugs
digoxin
03
Conditions
arrhythmiaheart failure (HF)Atrial fibrillation (AFib)
Beyond the preview
Go deeper on IRCT20110512006463N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110512006463N2.